EUVIMEDEUVIMED entdecken
Crossref

Sumac liposomes/mesenchymal stem cells fight methotrexate‐induced nephrotoxicity in rats via regulating Nrf‐2/Keap‐1/HO‐1 and apoptotic signaling pathways

Eman Maher Zahran, Reham H Mohyeldin, Hesham Refaat, Hesham A Abou-Zied, Mai H ElNaggar, Ghada M Abbas, Sherif A Maher, Entesar Ali Saber, Mohamed A Zarka, Mahmoud A Elrehany, Usama Ramadan Abdelmohsen

Archiv der Pharmazie · 2025-01 · 358 (1)

DOI: 10.1002/ardp.202400684 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archiv der Pharmazie, online erschienen am 16.11.2024. Verfasst von Eman Maher Zahran und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacognosy, Faculty of Pharmacy, Deraya University, New Minia, Egypt. Hauptthemen laut MEDLINE: Methotrexate, NF-E2-Related Factor 2, Apoptosis, Kelch-Like ECH-Associated Protein 1. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: None.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Methotrexate (MTX) is commonly employed in cancer treatment, but its clinical use is restricted due to the MTX‐associated renal injury. This study investigates the combined potential of Rhus coriaria (sumac) and bone marrow mesenchymal stem cells (BMMSCs) against MTX‐induced nephrotoxicity in rats. The high‐resolution‐liquid chromatography‐mass spectrometry (HR‐LC‐MS) of sumac extract tentatively identified 22 phytochemicals, mostly flavonoids, anthocyanins, and steroids. Preparation of sumac liposomes attained a suitable particle size of 3041.33 ± 339.42 nm, a polydispersity index of 0.208 ± 0.086, and an encapsulation efficiency of 84.92 ± 3.47%. Rat BMMSCs were injected into the tail vein of the experimental rats (0.5 × 10 6 cells, intravenous [iv]) of seven treated groups. The experimental design relies on either pre‐ or posttreatment of rats with intraperitoneal (IP) sumac liposomes (SL) (200 mg/kg, daily with a dose of MTX (300 µg/kg/14 days). The histopathological examination and serum analysis of creatinine and urea revealed good results, besides regulating levels of oxidative stress and inflammatory markers. Additionally, a significant decrease in the gene expression levels of B‐Cell Lymphoma 2 (Bcl‐2) and caspases‐3 and −9, a remarkable increase in the Bcl‐2 Associated X‐Protein (Bax), nuclear factor erythroid 2‐related factor 2 (Nrf2), and heme‐oxygenase 1 expression, and a downregulation of Kelch‐like ECH‐associated protein 1 (Keap1). Collectively, the coadministration of SL with BMMSCs might be a potent therapeutic strategy for attenuation of MTX‐induced renal damage. The network pharmacology analysis identified the involved key hub genes as KEAP1, Nrf2, HMOX1, mitogen‐activated protein kinase (MAPK1), nuclear factor‐kappa B (NF‐KB), interleukin‐1 beta (IL‐1B), and caspase‐3. The docking results revealed strong binding affinities of 7‐ O ‐methyl‐cyanidin‐3‐ O ‐(2″‐galloyl)‐galactoside with Keap1 and amentoflavone with MAPK. These insights pave the way for future experimental validation and therapeutic development of sumac‐based phytoconstituents against MTX‐induced nephrotoxicity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MethotrexateNF-E2-Related Factor 2ApoptosisKelch-Like ECH-Associated Protein 1LiposomesSignal TransductionAnimalsRatsMaleMesenchymal Stem CellsHeme Oxygenase (Decyclizing)Plant ExtractsKidneyOxidative StressKidney DiseasesRats, Sprague-DawleyHeme Oxygenase-1

Stichwörter der Autor:innen

BMMSCsKeap1/Nrf‐2/HO‐1methotrexatenephrotoxicitysumac

Substanzen

MethotrexateNF-E2-Related Factor 2Kelch-Like ECH-Associated Protein 1KEAP1 protein, ratLiposomesNfe2l2 protein, ratHmox1 protein, ratHeme Oxygenase (Decyclizing)Plant ExtractsHeme Oxygenase-1

Autor:innen und Institutionen

  • Department of Pharmacognosy, Faculty of Pharmacy, Deraya University, New Minia, Egypt.
  • Department of Pharmacology and Toxicology, Faculty of Pharmacy, Deraya University, New Minia, Egypt.
  • Deraya Center for Scientific Research, Deraya University, New Minia, Egypt.
  • Department of Pharmaceutical Sciences and Experimental Therapeutics, College of Pharmacy, University of Iowa, Iowa City, Iowa, USA.
  • Department of Medicinal Chemistry, Faculty of Pharmacy, Deraya University, Minia, Egypt.
  • Department of Pharmacognosy, Faculty of Pharmacy, Kafrelsheikh University, Kafrelsheikh, Egypt.

Förderung

  • None

Zitieren

APA

Zahran, E. M., Mohyeldin, R. H., Refaat, H., Abou-Zied, H. A., ElNaggar, M. H., Abbas, G. M., Maher, S. A., Saber, E. A., Zarka, M. A., Elrehany, M. A., & Abdelmohsen, U. R. (2025). Sumac liposomes/mesenchymal stem cells fight methotrexate‐induced nephrotoxicity in rats via regulating Nrf‐2/Keap‐1/HO‐1 and apoptotic signaling pathways. Archiv der Pharmazie, 358(1). https://doi.org/10.1002/ardp.202400684

Vancouver

Zahran EM, Mohyeldin RH, Refaat H, Abou-Zied HA, ElNaggar MH, Abbas GM, et al. Sumac liposomes/mesenchymal stem cells fight methotrexate‐induced nephrotoxicity in rats via regulating Nrf‐2/Keap‐1/HO‐1 and apoptotic signaling pathways. Archiv der Pharmazie. 2025;358(1). doi:10.1002/ardp.202400684

BibTeX
@article{Zahran2025,
  author = {Zahran, Eman Maher and Mohyeldin, Reham H and Refaat, Hesham and Abou-Zied, Hesham A and ElNaggar, Mai H and Abbas, Ghada M and Maher, Sherif A and Saber, Entesar Ali and Zarka, Mohamed A and Elrehany, Mahmoud A and Abdelmohsen, Usama Ramadan},
  title = {Sumac liposomes/mesenchymal stem cells fight methotrexate‐induced nephrotoxicity in rats via regulating Nrf‐2/Keap‐1/HO‐1 and apoptotic signaling pathways},
  journal = {Archiv der Pharmazie},
  year = {2025},
  volume = {358},
  number = {1},
  doi = {10.1002/ardp.202400684}
}
Kostenlos starten →